Challenges, Opportunities For Cardinal In China Policy Change
Major US pharma distributor Cardinal Health is further expanding its regional presence in China, with the country’s rapidly changing operating environment presenting opportunities and challenges.
You may also be interested in...
A shift in dispensing from hospitals to external pharmacies has led to predictions that the direct-to-patient sales model will be big in China. But only those with the right partnerships and expertise will reap the benefits, leading pharmacy chain executives told a recent conference.
Manipulation of China’s “fapiao”, or receipt system, is not new but now the State Council is cracking down on the practice, aiming to bring down inflated drug prices. Meanwhile, several provinces are cutting wholesale layers in a wider campaign to squeeze price inflation out of the commercial pharma segment.
U.S. distributor Cardinal Health goes full speed ahead in China. It has bought local players to tap into the regional market, doubled direct-to-patient pharmacies, and provided pharmacy management services to large hospitals among endeavors in the past three and a half years with more to come.